We are live on
!
Find out more
DBG
De Burlo Group Portfolio holdings
AUM
$441M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+5.04%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$411M
AUM Growth
+$50.3M
(+14%)
Cap. Flow
+$49.2M
Cap. Flow
% of AUM
11.98%
Top 10 Holdings %
Top 10 Hldgs %
32.14%
Holding
110
New
12
Increased
20
Reduced
51
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognex
CGNX
|
+$13.5M |
| 2 |
Citigroup
C
|
+$12.5M |
| 3 |
SBNY
Signature Bank
SBNY
|
+$10.2M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$9.99M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$9.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$6.46M |
| 2 |
Edwards Lifesciences
EW
|
+$5.78M |
| 3 |
Crown Castle
CCI
|
+$5.48M |
| 4 |
AvalonBay Communities
AVB
|
+$5.09M |
| 5 |
Zimmer Biomet
ZBH
|
+$3.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.06% |
| 2 | Healthcare | 18.77% |
| 3 | Financials | 18.27% |
| 4 | Communication Services | 9.26% |
| 5 | Consumer Discretionary | 8.01% |
Similar funds
ECA
DWML
BOA
PLU
CPW
CAAM
SCP
EFMC
De Burlo Group's Q4 2016 Portfolio in Review
As of Q4 2016, De Burlo Group held 110 positions worth $411M, up 14% from $360M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
De Burlo Group deployed $49.2M of net new capital in Q4 2016, opening 12 new positions and adding to 20 existing holdings. Its largest new stake was Cognex: 470,800 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $6.46M trimmed.
- De Burlo Group's largest Q4 2016 buy was Cognex: 470,800 shares worth $15M.
- De Burlo Group added most to Berkshire Hathaway Class B in Q4 2016, an estimated $9.99M increase.
- De Burlo Group's biggest Q4 2016 reduction was Thermo Fisher Scientific, cutting an estimated $6.46M.
- De Burlo Group fully exited AvalonBay Communities in Q4 2016, selling an estimated $5.09M.
- De Burlo Group's ten largest holdings make up 32% of its $411M portfolio in Q4 2016.
- De Burlo Group opened 12 new positions and closed 15 in Q4 2016.
- De Burlo Group's portfolio value rose 14% quarter-over-quarter to $411M.
Based on De Burlo Group's 13F filing for Q4 2016, filed 10 Feb 2017.